Innovative Asset Advisors Group’s Apellis Pharmaceuticals APLS Stock Holding History

Innovative Asset Advisors Group’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$40	–	324
2026 Q1	$40	Buy	+1	New	+$22	﹤0.01%	1034

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Innovative Asset Advisors Group's APLS Position: Q2 2026 in Review

Innovative Asset Advisors Group sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1 share — an estimated $40 sold.

Innovative Asset Advisors Group first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $40 in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Innovative Asset Advisors Group reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Innovative Asset Advisors Group sold 1 Apellis Pharmaceuticals share in Q2 2026, an estimated $40.
Innovative Asset Advisors Group first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Innovative Asset Advisors Group's Apellis Pharmaceuticals position peaked at $40 in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.